SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-402466
Filing Date
2013-10-17
Accepted
2013-10-17 16:17:07
Documents
4
Period of Report
2013-10-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d613333d8k.htm 8-K 22066
2 EX-3.1 d613333dex31.htm EX-3.1 3680
3 EX-99.1 d613333dex991.htm EX-99.1 6392
4 GRAPHIC g613333img001.jpg GRAPHIC 14907
  Complete submission text file 0001193125-13-402466.txt   54210
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 131156708
SIC: 2836 Biological Products, (No Diagnostic Substances)